Sodium-hydrogen exchange regulatory factor: Difference between revisions

Michal Harel (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
 
(4 intermediate revisions by the same user not shown)
Line 4: Line 4:
== Function ==
== Function ==


'''Sodium-hydrogen exchange regulatory factors''' (NHERF) or '''ezrin-radixin-moesin binding phosphoprotein-50''' or '''PDZ domain-containing protein''' or '''Na+/H+ exchange regulatory cofactor NHE-RF1''' or '''NHERF''' are multifunctional adaptor protein which plays a role in the assembly of signal transduction complexes, linking ion channels and receptors to the actin skeleton<ref>PMID:11141479</ref>. NHERF-1 is the major isoform present in the brain and it regulates the trans-cellular ion transport through the blood-brain barrier membrane<ref>PMID:26010555</ref>.
'''Sodium-hydrogen exchange regulatory factors''' (NHERF) or '''ezrin-radixin-moesin binding phosphoprotein-50''' or '''PDZ domain-containing protein''' or '''Na+/H+ exchange regulatory cofactor NHE-RF1''' or '''NHERF''' are multifunctional adaptor protein which plays a role in the assembly of signal transduction complexes, linking ion channels and receptors to the actin skeleton<ref>PMID:11141479</ref>.  
* '''NHERF-1''' is the major isoform present in the brain and it regulates the trans-cellular ion transport through the blood-brain barrier membrane<ref>PMID:26010555</ref>.  It transduces cyclic AMP signals that inhibit the sodium-hydrogen exchanger present at the surface of kidney and gut<ref>PMID:12586353</ref>.  NHERF-1 contains 2 PDZ domains and one erm domain.
* '''NHERF-2''' is a negative regulator of endothelial proliferation and may have important roles in endothelial homeostasis and vascular modeling<ref>PMID:22343917</ref>.  NHERF-2 contains 2 PDZ domains and one erm domain.
*'''NHERF-3''' contains 4 PDZ domains no erm domain<ref>PMID:15905209</ref>.


== Relevance ==
== Relevance ==

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Joel L. Sussman